Overview

What they do
Europe's first venture capital firm to focus solely on investments into psychedelic healthcare companies. Ten investments already executed with more in the pipeline.
neokuma.co
What they look for
Psychedelic compounds have been recognised by the FDA as breakthrough treatments that address the root causes of mental illness. We work with science-led teams advancing and redefining the standard of patient care that could help over 350 million patients worldwide.
neokuma.co
Stage
Seed
neokuma.co
Sectors
Healthcare
neokuma.co
Based
London, GB
neokuma.co

Sources

2026-08-26neokuma.coLargest European VC fund with a reputation for discipline and diligence

Portfolio, cheque size and the rest

The 10 companies they have backed that we can see, the cheque they write, and whether they are deploying right now.

Start free, no cardFree accounts see every record.